BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 19289115)

  • 1. Expression and functional evidence of the prostaglandin F2alpha receptor mediating contraction in human umbilical vein.
    Errasti AE; del-Rey G; Cesio CE; Souza G; Nowak W; Pelorosso FG; Daray FM; Rothlin RP
    Eur J Pharmacol; 2009 May; 610(1-3):68-74. PubMed ID: 19289115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of adrenaline vasoconstrictor response by sub-threshold concentrations of U-46619 in human umbilical vein: involvement of smooth muscle prostanoid TP(alpha) receptor isoform.
    Errasti AE; Luciani LI; Cesio CE; Tramontano J; Boveris D; Daray FM; Nowak W; Pelorosso FG; Rothlin RP
    Eur J Pharmacol; 2007 May; 562(3):227-35. PubMed ID: 17362923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human trabecular meshwork cell responses induced by bimatoprost, travoprost, unoprostone, and other FP prostaglandin receptor agonist analogues.
    Sharif NA; Kelly CR; Crider JY
    Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):715-21. PubMed ID: 12556403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic FP-prostaglandin-induced contraction of rat uterus smooth muscle in vitro.
    Sharif NA
    Prostaglandins Leukot Essent Fatty Acids; 2008 Mar; 78(3):199-207. PubMed ID: 18375109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bimatoprost-induced calcium signaling in human T-cells does not involve prostanoid FP or TP receptors.
    Chen J; Lu RT; Lai R; Dinh T; Paul D; Venadas S; Wheeler LA
    Curr Eye Res; 2009 Mar; 34(3):184-95. PubMed ID: 19274525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of prostanoid receptors mediating vasoconstriction in human umbilical vein.
    Daray FM; Minvielle AI; Puppo S; Rothlin RP
    Br J Pharmacol; 2003 Aug; 139(8):1409-16. PubMed ID: 12922927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies using isolated uterine and other preparations show bimatoprost and prostanoid FP agonists have different activity profiles.
    Chen J; Senior J; Marshall K; Abbas F; Dinh H; Dinh T; Wheeler L; Woodward D
    Br J Pharmacol; 2005 Feb; 144(4):493-501. PubMed ID: 15678094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AL-8810: a novel prostaglandin F2 alpha analog with selective antagonist effects at the prostaglandin F2 alpha (FP) receptor.
    Griffin BW; Klimko P; Crider JY; Sharif NA
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1278-84. PubMed ID: 10454504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-time intracellular Ca2+ mobilization by travoprost acid, bimatoprost, unoprostone, and other analogs via endogenous mouse, rat, and cloned human FP prostaglandin receptors.
    Kelly CR; Williams GW; Sharif NA
    J Pharmacol Exp Ther; 2003 Jan; 304(1):238-45. PubMed ID: 12490597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Hydroxytryptamine(1F) receptors do not participate in vasoconstriction: lack of vasoconstriction to LY344864, a selective serotonin(1F) receptor agonist in rabbit saphenous vein.
    Cohen ML; Schenck K
    J Pharmacol Exp Ther; 1999 Sep; 290(3):935-9. PubMed ID: 10454462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FP prostanoid receptor-mediated induction of the expression of early growth response factor-1 by activation of a Ras/Raf/mitogen-activated protein kinase signaling cascade.
    Xu W; Chou CL; Sun H; Fujino H; Chen QM; Regan JW
    Mol Pharmacol; 2008 Jan; 73(1):111-8. PubMed ID: 17911534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2-derived prostaglandin F2alpha mediates endothelium-dependent contractions in the aortae of hamsters with increased impact during aging.
    Wong SL; Leung FP; Lau CW; Au CL; Yung LM; Yao X; Chen ZY; Vanhoutte PM; Gollasch M; Huang Y
    Circ Res; 2009 Jan; 104(2):228-35. PubMed ID: 19096033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FP-receptor mediated trophic effects of prostanoids in rat ventricular cardiomyocytes.
    Pönicke K; Giessler C; Grapow M; Heinroth-Hoffmann I; Becker K; Osten B; Brodde OE
    Br J Pharmacol; 2000 Apr; 129(8):1723-31. PubMed ID: 10780979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells.
    Sharif NA; Kelly CR; Crider JY; Williams GW; Xu SX
    J Ocul Pharmacol Ther; 2003 Dec; 19(6):501-15. PubMed ID: 14733708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of a novel antiglaucoma agent, Bimatoprost (AGN 192024).
    Woodward DF; Krauss AH; Chen J; Liang Y; Li C; Protzman CE; Bogardus A; Chen R; Kedzie KM; Krauss HA; Gil DW; Kharlamb A; Wheeler LA; Babusis D; Welty D; Tang-Liu DD; Cherukury M; Andrews SW; Burk RM; Garst ME
    J Pharmacol Exp Ther; 2003 May; 305(2):772-85. PubMed ID: 12606640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonist activity of bimatoprost, travoprost, latanoprost, unoprostone isopropyl ester and other prostaglandin analogs at the cloned human ciliary body FP prostaglandin receptor.
    Sharif NA; Kelly CR; Crider JY
    J Ocul Pharmacol Ther; 2002 Aug; 18(4):313-24. PubMed ID: 12222762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoactive responses of U46619, PGF2alpha, latanoprost, and travoprost in isolated porcine ciliary arteries.
    Vysniauskiene I; Allemann R; Flammer J; Haefliger IO
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):295-8. PubMed ID: 16384976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replacement of the carboxylic acid group of prostaglandin f(2alpha) with a hydroxyl or methoxy substituent provides biologically unique compounds.
    Woodward DF; Krauss AH; Chen J; Gil DW; Kedzie KM; Protzman CE; Shi L; Chen R; Krauss HA; Bogardus A; Dinh HT; Wheeler LA; Andrews SW; Burk RM; Gac T; Roof MB; Garst ME; Kaplan LJ; Sachs G; Pierce KL; Regan JW; Ross RA; Chan MF
    Br J Pharmacol; 2000 Aug; 130(8):1933-43. PubMed ID: 10952685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin antagonism: effects of FP receptor agonists prostaglandin F2alpha and fluprostenol on trabecular meshwork contractility.
    Thieme H; Schimmat C; Münzer G; Boxberger M; Fromm M; Pfeiffer N; Rosenthal R
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):938-45. PubMed ID: 16505027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of 5-HT receptor subtypes mediating contraction in human umbilical vein. 1. Evidence of involvement of 5-HT2A receptors using functional and radioligand binding assays.
    Rogines-Velo MP; Pelorosso FG; Zold CL; Nowak W; Pesce GO; Sardi SP; Brodsky PT; Rothlin RP
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Dec; 366(6):587-95. PubMed ID: 12444501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.